The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
May 9th 2024
The results also showed that the PET scans could show damage to the individual’s brains, which was correlated with disability and fatigue.
Alzheimer's Association Launches "The Longest Day" Event
June 18th 2012On June 20th, 2012, the longest day of the year, the Alzheimer's Association is asking participants to run, walk, bike, or engage in some kind of endurance activity for 16 consecutive hours to honor those facing Alzheimer's disease.
Read More
SXC Health Solutions Receives URAC Specialty Pharmacy Accreditation
June 18th 2012SXC Health Solutions Corp announced that it has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry.
Read More
Phase 3 study findings showed that patients with active moderate to severe rheumatoid arthritis (RA) who received an investigational intravenous (IV) formulation of the anti-tumor necrosis factor (TNF)-alpha therapy Simponi (golimumab) demonstrated significant improvements in signs, symptoms, and disease activity.
Read More
Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
June 13th 2012Argus Health Systems, Inc, a leading transparent pharmacy benefits administrator, recently announced that it has established a Preferred Specialty Program with Amber Pharmacy to provide expanded network options.
Read More
FDA Approves Genentech, Inc's Perjeta for HER2-Positive Metastatic Breast Cancer
June 11th 2012The FDA approved Genentech, Inc's pertuzumab injection (Perjeta) for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Read More
Diplomat Specialty Pharmacy Names Industry Veteran, Gary Kadlec, New Company President
June 11th 2012Diplomat Specialty Pharmacy, the nation's largest, privately owned specialty pharmacy, announced that pharmacy executive, Gary W. Kadlec, has joined the company and will be serving as president.
Read More
New efficacy and safety data from the Phase 3 PHOENIX 1 study, 1 of 2 pivotal registration trials, showed that maintenance treatment with Stelara (ustekinumab) for up to 5 years resulted in consistent, significant clinical response in adults with moderate to severe plaque psoriasis.
Read More
Cardinal Health Specialty Solutions Launches PathWare Decision Support Transaction Solutions
May 29th 2012Cardinal Health Specialty Solutions today launched PathWare Decision Transaction Solutions, a new technology system that makes it easier for payors and physicians to work together to implement programs that improve the quality and cost of caring for patients.
Read More
Regulatory Authorities Accept Oral BG-12 Marketing Applications For Review
May 11th 2012Biogen Idec recently announced that United States and European Union regulatory authorities have accepted the company's marketing applications for the review of BG-12 (dimethyl fumarate), an oral therapeutic candidate for the treatment of multiple sclerosis (MS).
Read More